These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation. Billman GE J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569 [TBL] [Abstract][Full Text] [Related]
23. [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children]. Fujino H; Fujiseki Y; Shimada M J Cardiol; 1989 Mar; 19(1):307-15. PubMed ID: 2810047 [TBL] [Abstract][Full Text] [Related]
24. [Comparative effects of inhalation anesthetics on atrioventricular conduction with and without calcium entry blockers]. Yokota S Hokkaido Igaku Zasshi; 1989 Jan; 64(1):43-54. PubMed ID: 2722126 [TBL] [Abstract][Full Text] [Related]
25. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. Opie LH Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329 [TBL] [Abstract][Full Text] [Related]
26. Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation. Lesh MD; Van Hare GF; Fitzpatrick AP; Griffin JC; Chu E J Electrocardiol; 1993; 26 Suppl():194-203. PubMed ID: 8189124 [TBL] [Abstract][Full Text] [Related]
27. [Anti-arrhythmia therapy with Ca++-antagonists]. Fazekas T Orv Hetil; 1989 Jun; 130(23):1195-200. PubMed ID: 2660063 [TBL] [Abstract][Full Text] [Related]
28. Verapamil: an effective calcium blocking agent for pediatric patients. Porter CJ; Garson A; Gillette PC Pediatrics; 1983 May; 71(5):748-55. PubMed ID: 6340050 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs. Singh BN Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905 [TBL] [Abstract][Full Text] [Related]
30. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats. Mertz TE; Kaplan HR J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307 [TBL] [Abstract][Full Text] [Related]
36. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias]. Lüderitz B Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070 [TBL] [Abstract][Full Text] [Related]
37. Effects of diltiazem on vulnerability to atrial and ventricular reentrant arrhythmias in the normal and ischemic heart. Heuer H; Gülker H; Thale J; Meyer M; Weiss U; Bendeer F Arzneimittelforschung; 1983; 33(8):1113-6. PubMed ID: 6685488 [TBL] [Abstract][Full Text] [Related]
38. [Significance of magnesium in cardiac arrhythmias]. Stühlinger HG; Kiss K; Smetana R Wien Med Wochenschr; 2000; 150(15-16):330-4. PubMed ID: 11105328 [TBL] [Abstract][Full Text] [Related]
39. Incidence and management of dysrhythmias after Fontan procedure. Porter CJ; Garson A Herz; 1993 Oct; 18(5):318-27. PubMed ID: 8258437 [TBL] [Abstract][Full Text] [Related]
40. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil. Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]